Diana Paolo, Money Dustin T, Gelvin Michael G, Lunardi Nadia
Anesthesiology, Università degli Studi di Padova, Padua, Italy.
Cardiovascular Perfusion, University of Virginia Health System, Charlottesville, VA, USA.
Case Rep Crit Care. 2017;2017:6740532. doi: 10.1155/2017/6740532. Epub 2017 Feb 26.
We describe a case of severe refractory hypoxemia requiring prolonged extra corporeal membrane oxygenation (ECMO) support in a case of postpartum acute respiratory distress syndrome (ARDS). The clinical course was marked by persistently poor lung compliance and several complications of ECMO, that is, significant hemolysis, hemothorax, and intracranial bleeding. We report marked improvement of lung mechanics and respiratory function, leading to accelerated separation from ECMO, following rescue administration of low dose methylprednisolone 24 days after the onset of ARDS. Corticosteroid treatment was safe and well tolerated. In contrast with the conclusions of the 2006 ARDS Network trial, our report establishes a case in support of the use of low dose methylprednisolone as a safe and effective rescue treatment option in selected subsets of patients with nonresolving ARDS.
我们描述了一例产后急性呼吸窘迫综合征(ARDS)患者出现严重难治性低氧血症,需要长时间体外膜肺氧合(ECMO)支持的病例。临床过程的特点是肺顺应性持续较差以及ECMO出现多种并发症,即严重溶血、血胸和颅内出血。我们报告,在ARDS发病24天后给予低剂量甲泼尼龙进行抢救治疗后,肺力学和呼吸功能显著改善,从而加快了ECMO撤机。皮质类固醇治疗安全且耐受性良好。与2006年ARDS网络试验的结论相反,我们的报告证实了在某些ARDS未缓解的患者亚组中,低剂量甲泼尼龙作为一种安全有效的抢救治疗选择的病例。